Last reviewed · How we verify

NCT07534397

Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation

Not yet recruiting NA Last updated 16 April 2026
What this trial tests

NA trial testing transcranial direct current stimulation in PARKINSON DISEASE (Disorder) in 20 participants. Not yet recruiting.

Timeline
1 May 2026
Primary endpoint
31 October 2027
31 October 2027

Quick facts

Lead sponsorThe University of Texas at Dallas
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment20
Start date1 May 2026
Primary completion31 October 2027
Estimated completion31 October 2027

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas at Dallas

Who can join

Adults 50 to 90, any sex, with PARKINSON DISEASE (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to examine the effects of transcranial Direct Current Stimulation (tDCS) on verbal retrieval and cognition and sensorimotor control and to determine if tDCS can be used as a way to improve retrieval, sensory, and motor abilities in individuals with Parkinson's disease (PD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for PARKINSON DISEASE (Disorder)

Currently open trials in the same condition.

Other The University of Texas at Dallas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07534397.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing